What We Do

Services
In the Press

October 4, 2016

UC San Diego Health Joins Precision Medicine Initiative to Tackle Pancreatic Cancer

Precision Promise brings together researchers, clinicians and drug developers, led by Dr. Andy Lowy.




May 20, 2016

Accelerated tech transfer between the drugmaker and the academic institution

The UCSD MCC and GSK collaboration is entitled "Discovery Partnerships with Academia" or DPAc. The May 2016 Technology Transfer Tactics issue interviews MCC Director of Industry Relations Ida Deichaite, PhD on page 70.




May 2, 2016

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed an agreement with UC San Diego to commercialize antibodies.




February 24, 2016

Emphasizing Collaboration at a Pivotal Moment in Cancer Research

MCC Director of Industry Relations Ida Deichaite, PhD's opinion article features the current cancer therapy landscape including the Cancer Moonshot and MCC symposium.




October 30, 2015

GSK’s Discovery Fast Tack Contract Starts With Super-Moon Eclipse

Catriona Jamieson, MD, PhD, leads bench-to-bedside project to treat leukemia by eliminating cancer stem cells.




September 2015

UC San Diego, GSK collaboration to eradicate cancer stem cells, treat leukemia

AACi Monthly newsletter features collaboration with Catriona Jamieson, MD, PhD.




August 25, 2015

Sequenom Enters Collaboration With UC San Diego Moores Cancer Center With Novel Liquid Biopsy Assay, featuring MCC Investigator Hatim Husain, MD, Assistant Professor of Medicine.




July 8, 2015

Researchers at UC San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminating cancer stem cells. The collaboration is part of GSK’s Discovery Partnerships with Academia (DPAc) program, where academic partners become core members of drug-hunting teams. MCC Investigator Catriona Jamieson, MD, PhD, associate professor of medicine and chief of the Division of Regenerative Medicine, will lead UC San Diego’s effort in the new DPAc team.




March 24, 2015

Biocept Enters Clinical Collaboration with University of California, San Diego Moores Cancer Center, featuring MCC Investigator Hatim Husain, MD, Assistant Professor of Medicine.




February 22, 2015

CIRM's Klein proposes $100B biomed program: Bob Klein describes his vision of how to increase biomedical funding to hasten discovery and commercialization of disease treatments. He spoke Thursday, Feb. 19, at the annual UCSD Moores Cancer Center symposium.




February 21, 2015

Fighting patient, fighting doctor: : Patient Theresa Blanda speaks about her experience battling cancer with the help of Moores Cancer Center Investigator Dr. Catriona Jamieson, at the 11th annual Industry/Academia Translational Oncology Symposium.




February 19, 2015

Katherine Connor from the San Diego Daily Transcript reports on the new funding paradigm needed for scientific research: Some of the nation’s top oncology researchers and private companies in the cancer space met at the University of California, San Diego Moores Cancer Center Thursday for the 11th annual Industry/Academic Translational Oncology Symposium.




February 13, 2015

The Union-Tribune published an opinion editorial by Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD, entitled "Finding Ways to create cancer-killing swords". The op-ed features the upcoming 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium on February 19, and the ongoing collaborations at MCC.




January 12, 2015

Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients. The lead investigator in the study is Assistant Professor of Hematology-Oncology Dr. Hatim Husain.




March 4, 2014

UC San Diego-Human Longevity Inc. Agreement Seeks to Accelerate Medical Science, featuring Moores Cancer Center Director Scott Lippman, MD, Professor of Medicine, Senior Associate Dean and Associate Vice Chancellor for Cancer Research and Care.




February 18, 2014

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and upcoming Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA.




December 12, 2013

California Institute for Regenerative Medicine approved a $4.18 million Disease Team grant, which will be lead by PI Moores Cancer Center Deputy Director for Research Dr. Thomas J. Kipps, and Co-PI Moores Cancer Center Director of Stem Cell Research Dr. Catriona Jamieson. This is a continuation of their work from a previous CIRM grant, which promises to move therapies out of the lab and into clinical trials in patients.




December 9, 2013

Reporter Bradley J. Fikes from The San Diego Union Tribune interviewed Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD for a Q&A: Inside Biotech for the Business Section. The interview discusses her role at MCC, bridging the gap between researchers and industry to create collaborations.




September 9, 2013

Sunrise 7's Sean Caldwell spoke with Moores Cancer Center Deputy Director for Research Dr. Thomas J. Kipps and Donald Sutherland, a man diagnosed with chronic lymphocytic leukemia (CLL) to help understand the constantly changing language of cancer.




April 11, 2013

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.




February 20, 2013

KPBS featured Moores Cancer Center Deputy Director for Research Dr. Thomas J. Kipps in a video report on February 20 to discuss how sequestration will impact San Diego's life science industry.




January 4, 2012

KPBS featured Moores Cancer Center developments in Multiple Myeloma in a video report on January 4. Drs. Catriona Jamieson and Erin Reid discuss their work.




November 10, 2011

CBS News’s Dr. Jon LaPook interviews Moores Cancer Center Investigator Dr. David Cheresh to discuss nanotechnology's impact on cancer treatment.




April 21, 2011

Health Sciences Communications releases a video covering the successful 7th "Industry/Academia Translational Oncology" Symposium.




October 2, 2010

Wall Street Journal covers I-SPY2 clinical trials paradigm, headed by 2011 keynote speaker Dr. Laura Esserman.




August 5, 2010

Life Technologies collaborates with Moores Cancer Center Team led by Dr. Kelly Frazer, Dr. Thomas Kipps, and Dr. Dennis Carson.




March 2, 2009

NBC San Diego Featured Coverage of 2009 Symposium: Science Comes to San Diego to Battle Cancer.




August 13, 2009

The New York Times released the article "Screening Could Lead to More Potent Cancer Drugs" highlighting theories suggesting that screening for specific cancer stem cells could lead to a more effective approach to eliminating cancerous tissues. The work and methodologies outlined in the article closely align with some of the work done at Moores UCSD Cancer Center.




March 23, 2009

760AM KFMB Talk Radio released the article "Stem Cell Surge Will Help San Diego's Economy" featuring Dr. Catriona Jamieson and her stem cell research at Moores UCSD Cancer Center. Many people in the field of stem cell research speculate that President Obama's lifting of the previous restriction of stem cell research funds will ultimately help boost economies as a result.




January 16, 2009

California Institute of Regenerative Medicine (CIRM) posted an interview with Dr. Catriona Jamieson, "Catriona Jamieson Talks About Therapies Based on Cancer Stem Cells" where she provides an overview of the progress of stem cell research as well as the stem cell research at Moores UCSD Cancer Center as well as describing basic mechanisms of cancer and cancer therapies.




« Back